Dermatology

Rosacea Treatment Guide: Azelaic Acid 15%, Medications & Management

Feature-based rosacea care, with an expanded guide to azelaic acid formulations, a 12-week response check, and irritation management.

How is rosacea treated, and where does azelaic acid 15% fit?

Rosacea treatment is matched to the features present. For inflammatory bumps, options include azelaic acid, ivermectin, and metronidazole, as outlined by the American Academy of Dermatology. Prescription azelaic acid 15% gel or foam is used for mild-to-moderate inflammatory papules and pustules; the gel label does not establish efficacy for redness alone. Both cited US formulations are used twice daily under their labels, with reassessment if there is no improvement after 12 weeks. OTC 10% products are not established as interchangeable with these prescription formulations. A licensed clinician can assess uncomplicated skin symptoms by an appropriate video or in-person visit; eye symptoms, uncertain diagnoses, and complex disease need appropriate in-person care.
Medically reviewed by Parth Bhavsar, MD. Updated September 27, 2026.
Medical Disclaimer: This guide is for educational purposes and does not constitute medical advice. Consult a licensed physician for diagnosis and treatment of your specific condition.

Key Clinical Points

  • Rosacea care is matched to the features present: bumps, persistent redness, visible vessels, or eye symptoms.[1][2]
  • Azelaic acid 15% gel and foam are FDA-labeled for the inflammatory papules and pustules of mild-to-moderate rosacea; the gel label says efficacy for redness without bumps has not been evaluated.[9][10]
  • The rosacea labeling and trials cited here cover the prescription 15% gel and foam, not OTC 10% cosmetic products.[9][10][11][12]
  • Topical response takes weeks; the azelaic acid labels call for reassessment if there is no improvement after 12 weeks.[4][9][10]
  • Excessive or persistent irritation from the gel calls for stopping it and contacting the prescriber, not pushing through; stop either product if an allergic reaction occurs.[9][10]
  • Eye involvement warrants ophthalmology input, and eye disease that threatens sight needs immediate referral.[1][4]
  • Gentle skin care, moisturizer, and sun protection are part of the treatment plan.[4][13]
Editorial medical illustration representing Rosacea
Rosacea: an evidence-based overview from the TeleDirectMD medical team.

What Is Rosacea?

Rosacea is a chronic inflammatory skin condition that primarily affects the central face, the cheeks, nose, chin, and forehead. A 2018 meta-analysis estimated that about 5.5% of the adult general population is affected (5.46%), with estimates varying by how rosacea was diagnosed; it was found in both women (5.41%) and men (3.90%), mostly between ages 45 and 60.[15] It is more common in Northern European populations,[1] occurs more often in fair-skinned people, and men in particular may develop marked enlargement of the nose (rhinophyma).[5]

Rosacea follows a relapsing course, with signs that fluctuate in severity.[5] Common triggers include alcohol, spicy foods, sun exposure, and stress, although specific triggers vary from person to person.[1] Experts have not agreed on whether the different rosacea patterns are separate conditions or points along one inflammatory spectrum, and no single treatment has been fully curative, so the goal of treatment is control.[1]

In clinical practice, rosacea patients often arrive frustrated, having tried over-the-counter products for months. The key shift in understanding is this: rosacea is not a cosmetic problem you can treat with more moisturizer. It is an inflammatory vascular disease that requires targeted medical management.

The Four Subtypes of Rosacea

The 2002 National Rosacea Society (NRS) classification described four subtypes based on the predominant clinical features. These remain a useful framework for organizing what you see, even as current guidelines have moved toward a more flexible phenotype-based approach.[1][2]

Subtype 1: Erythematotelangiectatic (ETR)

This is the most common subtype in pooled estimates, characterized by persistent central facial redness and a history of recurrent flushing or blushing.[1] You may notice visible small blood vessels (telangiectasia) under the skin surface, particularly around the nose and cheeks. The skin often burns, stings, or feels tight, especially after temperature changes. Wind, sun, hot beverages, and emotional stress are frequent triggers. In darker skin tones, the redness may appear as a brown or purple discoloration rather than a classic red flush.

Subtype 2: Papulopustular

Papulopustular rosacea features persistent central facial redness accompanied by transient acne-like papules (red bumps) and pustules (pus-filled bumps). This subtype is commonly mistaken for acne, but important distinguishing features are a lack of blackheads or whiteheads (comedones), rare involvement beyond the face, and the presence of flushing.[5] Under the microscope, rosacea pustules often show a superficial collection of neutrophils extending beyond the follicle, which also helps distinguish rosacea from acne.[1] Perioral and perinasal involvement can occur, and burning or stinging sensations are common.

Subtype 3: Phymatous

Phymatous rosacea involves progressive skin thickening, irregular nodularities, and enlargement of affected areas. Rhinophyma, enlargement and irregular thickening of the nose, is the most recognizable form. Phymatous changes can also affect the chin (gnathophyma), forehead (metophyma), cheeks, and ears. Marked enlargement of the nose develops in men in particular.[5] Isotretinoin may keep thickened skin from growing thicker, but it cannot remove skin that has already thickened; chronic, severe phymatous disease may need surgical or ablative laser treatment.[1][4]

Subtype 4: Ocular Rosacea

Ocular rosacea affects the eyes and eyelids. Eye involvement is an important, underdiagnosed complication, and it may occur without skin signs.[5] The NRS states that about 20% of patients have eye findings before skin findings,[2] and one published case describes a woman whose ocular rosacea went undiagnosed for 10 years until facial signs appeared.[8] Features can include a foreign body sensation, eyelid telangiectasia, frequent chalazia (eyelid lumps), blepharitis, conjunctivitis, and corneal ulcers. People with eye involvement should be referred to ophthalmology to reduce the risk of vision loss.[1]

The Shift to Phenotype-Based Management

In 2017, the NRS Expert Committee updated the rosacea classification system to move away from rigid subtype labels toward a phenotype-based approach. The reasoning was straightforward: most patients have overlapping features, and treatment should target the specific signs and symptoms present, not a subtype category.[1]

Under this framework, clinicians assess each of the following phenotypes and assign treatment accordingly:[1][2]

  • Fixed centrofacial erythema (diagnostic criterion)
  • Phymatous changes (also diagnostic)
  • Papules and pustules (major feature)
  • Flushing/transient erythema (major feature)
  • Telangiectasia (major feature)
  • Ocular manifestations (major feature)
  • Burning or stinging, edema, dry appearance (secondary features)

Under the NRS framework, one diagnostic phenotype, or two or more major phenotypes, may be considered diagnostic.[2] What this means practically is that I assess each patient as an individual, a person with primarily persistent redness will receive different therapy than someone whose main complaint is inflammatory papules, even if they technically fall under the same "subtype."

Clinical Pearl

Many patients with papulopustular rosacea also have significant background redness (ETR features). Treating only the bumps may leave the redness untouched. Combination therapy is often used when features overlap, and several topical and oral combinations have outperformed monotherapy in trials.[1]

Topical Medications

Topical therapies have the highest level of evidence in rosacea, and most patients with papules and pustules can be treated with topical metronidazole, azelaic acid, or ivermectin.[1]

Ivermectin 1% Cream (Soolantra)

Ivermectin 1% cream is applied once daily and is labeled for the inflammatory lesions of rosacea; the NRS describes it for the bumps and pimples of moderate to severe rosacea.[3][17] In a 16-week randomized, investigator-blinded trial of 962 people with moderate to severe papulopustular rosacea, once-daily ivermectin 1% reduced inflammatory lesions more than twice-daily metronidazole 0.75% cream (83.0% versus 73.7%), more patients were clear or almost clear (84.9% versus 75.4%), and local tolerability was better with ivermectin.[16] It has anti-parasitic activity against Demodex mites and anti-inflammatory effects, including lower IL-1β and TNF-α.[1] In its US label trials, the most common adverse reactions, each at 1% or less, were skin burning and skin irritation.[17]

Metronidazole 0.75% and 1%

Metronidazole is an established option for the papules and pustules of rosacea.[3][14] It is available by prescription as a 0.75% gel, cream, or lotion and as a 1% gel or cream, applied once or twice daily as directed.[3] It has anti-inflammatory properties; in trials both the 1% cream and the 0.75% gel reduced lesion counts and erythema, and tolerability improved when it was combined with a gentle cleanser, moisturizing, and sunscreen.[1]

Azelaic Acid 15% (Finacea)

Prescription azelaic acid gel and foam are options for inflammatory papules and pustules of mild-to-moderate rosacea. Efficacy for redness alone is not established by the gel label. See the formulation comparison and application and safety guide below.[3][9][10]

Brimonidine Gel 0.33% (Mirvaso)

Brimonidine 0.33% gel is an alpha adrenergic agonist labeled for persistent (nontransient) facial redness of rosacea, applied as a pea-sized amount once daily; its indication does not include papules or pustules.[18] Brimonidine gel and oxymetazoline cream can fade persistent redness for up to 12 hours.[4] A clinically important caution: the label describes a rebound phenomenon in which redness returned worse, and it advises caution in people with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, and certain other vascular conditions.[18]

Topical rosacea medications at a glance, from the NRS list of FDA-approved treatments and US labels[1][3][9][17][18][19]
Medication Formulation Target Phenotype Dosing
Ivermectin 1% (Soolantra) Cream Papules, pustules Once daily
Metronidazole 0.75-1% Cream, gel, lotion Papules, pustules, mild erythema Once or twice daily
Azelaic acid 15% (Finacea) Gel, foam Papules and pustules; not established for redness alone Twice daily
Brimonidine 0.33% (Mirvaso) Gel Persistent facial erythema Once daily
Oxymetazoline 1% (Rhofade) Cream Persistent facial erythema Once daily

Azelaic Acid for Rosacea: 10% vs. 15%, Gel vs. Foam

Is prescription azelaic acid worth discussing for rosacea?

If your rosacea includes inflammatory bumps and pustules, prescription azelaic acid 15% is one evidence-based topical option. It is not a cure, and the best choice depends on which features you have, how sensitive your skin is, and what you have already tried. The US gel and foam labels cover the inflammatory papules and pustules of mild-to-moderate rosacea.[3][4][9][10][14]

Redness needs a more precise answer. Redness accompanying inflammatory bumps can improve as the inflammation settles. The gel label specifically says effectiveness for redness without papules or pustules has not been evaluated. Persistent flushing or visible vessels may need a different treatment plan; do not assume an azelaic-acid serum will address every form of facial redness.[1][9][11]

Is OTC azelaic acid 10% the same as prescription 15%?

No equivalence should be assumed. The prescription 15% gel and foam have formulation-specific rosacea trials and US labeling. A cosmetic product marketed with 10% azelaic acid is not interchangeable simply because it contains the same named ingredient. Concentration, vehicle, other ingredients, and the condition being treated all matter. The evidence reviewed for this update did not establish that an OTC 10% product produces the same rosacea outcomes as prescription 15%.[9][10][11][12]

Azelaic acid formulations: compare the actual product, not only the percentage.[9][10][11][12]
FormulationWhat the evidence supportsPractical distinction
OTC 10% cosmetic productsNot established as equivalent to the prescription rosacea formulations reviewed hereCheck the full ingredient list; do not infer FDA rosacea approval from the ingredient name
Prescription 15% gelInflammatory bumps in mild-to-moderate rosacea; vehicle-controlled and metronidazole-comparison trialsThin layer twice daily under its label; local stinging and irritation can occur
Prescription 15% foamInflammatory bumps in mild-to-moderate rosacea; vehicle-controlled trialsShake before use, apply a thin layer twice daily; flammable propellant precautions apply

Azelaic acid gel versus foam: is one better?

Both have evidence for papulopustular rosacea. The foam trial compared foam with its vehicle, not with azelaic acid gel. The gel trials used different populations, protocols, and assessment methods. Comparing irritation percentages across those separate studies cannot prove that one formulation is gentler or more effective for you. Selection can reasonably consider the formulation you tolerate, access, and cost, with the prescriber confirming the specific product.[9][10][12]

The formulation changes the evidenceThe formulation changes the evidenceSame ingredient does not establish interchangeable rosacea outcomes.10% cosmetic productsDo not assume equivalence to a tested prescription product.15% prescription gelEvidence for inflammatory papules and pustules.15% prescription foamAlso supported by trials; not proven superior to gel here.
Formulation-specific evidence and labels, not a head-to-head ranking.[9][10][11][12] Swipe horizontally on a small screen.

Azelaic acid versus metronidazole: what did the trial show?

A 15-week randomized trial involving 251 patients compared twice-daily 15% azelaic acid gel with twice-daily 0.75% metronidazole gel. Mean inflammatory-lesion reduction was 72.7% versus 55.8%, favoring azelaic acid. Neither treatment produced a clinically appreciable improvement in visible small vessels. This is evidence about those two formulations in that study, not proof that every patient should switch from metronidazole or that foam gives the same comparative result.[11]

Metronidazole remains an established rosacea option. A systematic review found high-certainty evidence for azelaic acid and ivermectin and moderate-certainty evidence for metronidazole in reducing papules and pustules. Treatment choice should include tolerability and prior response, not just one percentage from one trial.[3][14]

How to Use Azelaic Acid: Timeline, Moisturizer, and Side Effects

How long does azelaic acid take to work?

Think in weeks, not overnight results. AAD guidance for topical rosacea medicines says a slight improvement may appear in 3 to 4 weeks, while a noticeable difference often takes 2 to 3 months. That is a general expectation, not a guaranteed azelaic-acid response time. The prescription gel and foam programs used 12-week treatment periods, and their labels call for reassessment if there is no improvement after 12 weeks.[4][9][10]

A realistic treatment timelineA realistic treatment timelineDo not wait for a scheduled check if a significant reaction develops.First weeks: monitor tolerabilityMild stinging can occur; persistent severe irritation is not a goal.3 to 4 weeks: possible early improvementAAD timing for topical rosacea medicines, not a guaranteed result.12 weeks: reassess if not improvingReview diagnosis, use, tolerability, and the treatment plan.
Timeline drawn from AAD guidance and US gel/foam labeling.[4][9][10] Swipe horizontally on a small screen.

Do you apply azelaic acid before or after moisturizer?

A simple starting sequence is gentle cleansing, patting dry, prescription medication, then moisturizer. AAD skin-care advice puts rosacea medication before moisturizer. The product labels say to cleanse gently and pat dry before application, and to wait until the medication has dried before applying cosmetics. Avoid scrubbing, abrasive products, alcohol-based toners, or peeling agents.[9][10][13]

Follow the instructions for your actual prescription rather than a routine copied from social media. Both cited US formulations are labeled for twice-daily use, but a clinician may adjust the plan if tolerability is a problem. Apply a thin layer, do not cover it with an occlusive dressing, and keep it away from the eyes, mouth, and other mucous membranes.[9][10]

What if azelaic acid burns or stings?

Burning, stinging, itching, dryness, or irritation can occur, especially early in treatment. Strong or persistent burning is not evidence that the medicine is “working,” and an inflamed rash should not automatically be labeled a purge. Stop and contact the prescriber if irritation is excessive or persistent, or if an allergic reaction occurs. A simpler cleanser/moisturizer routine can reduce unnecessary irritation, but it does not replace reassessment of a significant reaction.[9][10][13]

Product-label cautions and practical next steps.[9][10][13]
What happensWhat to do
Brief mild stinging or drynessReview gentle skin care and discuss tolerability if it persists; do not add more irritating products
Excessive or persistent irritationStop use and contact the prescriber
New abnormal lightening of the skinReport the change; the labels warn about hypopigmentation
Worsening asthma or wheezingSeek prompt medical advice; severe breathing difficulty needs emergency care
Facial/throat swelling or breathing trouble suggesting a serious allergic reactionStop the product and obtain emergency care
Eye exposureRinse with plenty of water; seek care if irritation persists or vision is affected

Foam-specific precaution: its propellant is flammable. Avoid fire, flame, and smoking during and immediately after application; follow the canister's storage and handling warnings. This is a formulation warning, not evidence that gel and foam have different clinical effectiveness.[10]

Can you use azelaic acid with tretinoin or other active products?

Do not automatically layer an acne or anti-aging routine onto sensitive rosacea skin. The azelaic-acid labels caution against abrasive and peeling products, and AAD recommends avoiding common irritating skin-care ingredients. If you already use tretinoin, an exfoliating acid, benzoyl peroxide, or another prescription topical, ask the prescriber to decide what to continue, separate, or stop. This is a tolerability precaution, not a claim that every combination is prohibited.[9][10][13]

No universal azelaic-acid/tretinoin schedule for rosacea was established in the evidence reviewed for this update. We therefore do not provide an unsupervised combination regimen. The clinician should account for whether you are treating rosacea, acne, another condition, or more than one problem.

Keep the routine simpleKeep the routine simpleA starting sequence; your prescription instructions take priority.Cleanse gently, then pat dryNo scrubs or harsh alcohol-based toners.Apply the prescribed thin layerKeep away from eyes and mucous membranes.Moisturize; protect skin from the sunMedication first; cosmetics after it dries.
Application sequence and skin-care guidance.[9][10][13] Swipe horizontally on a small screen.

What if treatment is not helping?

If symptoms are not controlled after 8 to 12 weeks of consistent use, a different topical agent or a systemic medicine may be considered,[1] and the azelaic acid labels call for reassessment after 12 weeks without improvement.[9][10] A licensed clinician can review the diagnosis, actual product, application routine, irritation, and whether the main problem is bumps, persistent redness, or both. One retrospective study found that asynchronous teledermatology for rosacea gave diagnostic concordance and treatment recommendations similar to in-person visits.[7] Eye pain, visual changes, severe swelling, uncertain diagnosis, or persistent treatment failure favors in-person or specialist assessment. Do not increase strength or keep layering new products without a review.

Oral Medications

Low-Dose Doxycycline 40 mg Modified-Release (Oracea)

Oracea (doxycycline 40 mg) is FDA-approved for only the inflammatory lesions (papules and pustules) of rosacea in adults.[20] It is prescribed at a sub-antimicrobial dose as a 40 mg capsule taken once daily, and the NRS also lists 40 mg extended-release oral minocycline for the bumps and pimples of rosacea.[1][3] The Oracea label notes that it has not been evaluated for the redness, visible vessels, or eye involvement of rosacea, and warns that doses above 40 mg may increase the likelihood of bacterial resistance.[20]

Its approval rests on two 16-week, placebo-controlled phase 3 trials involving 537 subjects, and a systematic review rated the evidence for doxycycline 40 mg modified release as moderate to high certainty for papules and pustules.[14][20] A clinical review reports efficacy similar to doxycycline 100 mg with fewer gastrointestinal side effects.[1] The label says to take one capsule in the morning on an empty stomach, preferably at least one hour before or two hours after meals, with adequate fluid to reduce the risk of esophageal irritation and ulceration.[20]

Ask the treating clinician how long to continue it alongside a topical agent. The patient information in the label says it is not known whether Oracea is effective for longer than 16 weeks or safe for longer than 9 months.[20]

Oral Isotretinoin

Isotretinoin is FDA-approved for severe recalcitrant nodular acne.[21] In rosacea it is used for severe or refractory disease, and a systematic review rated its evidence for papules and pustules as moderate to high certainty.[14] Regimens studied in rosacea have used lower daily doses than standard acne dosing, including continuous low-dose (microdose) courses, which still require regular laboratory monitoring and contraception for anyone who could become pregnant.[1] It may keep thickened skin from growing thicker but cannot remove skin that has already thickened.[4]

Isotretinoin can cause life-threatening birth defects and is available only through the restricted iPLEDGE REMS program; its label calls for fasting lipid tests before treatment and periodic liver function tests.[21] This is not a medication to be started over telehealth; it needs in-person dermatology management. Referral is appropriate for any patient in this category.

The Demodex Connection

Demodex mites are commensal skin mites, and Demodex infestation is more common in people with rosacea than in healthy controls. Their role is one part of a complex inflammatory condition, not proof that rosacea is simply an infestation.[1]

The mechanisms linking Demodex to rosacea inflammation are an active area of research. One proposed pathway is that Demodex antigens sensitize and activate Toll-like receptor 2 (TLR-2) on keratinocytes, a receptor that is highly active in rosacea, amplifying the innate immune response.[1]

Topical ivermectin has anti-inflammatory and anti-Demodex activity. In a 2022 prospective study of people with papulopustular rosacea, ivermectin 1% cream led to complete response in 70% of patients, and the median time to relapse was 140 days.[6]

The role of Demodex does not mean rosacea is simply a mite infestation. Many people without rosacea also carry Demodex, and rosacea inflammation also involves immune dysregulation, changes in small blood vessels, the skin microbiome, genetic factors, and environmental triggers.[1]

Identifying and Avoiding Your Triggers

Identifying and avoiding your own triggers is a core, low-cost part of rosacea care. Common triggers include alcohol, spicy foods, sun exposure, and stress, but specific triggers vary between patients.[1] The NRS algorithms list identifying and avoiding environmental and lifestyle triggers as part of managing persistent redness.[2]

Top Rosacea Triggers

  • Sun exposure, the sun can worsen rosacea any time of the year. The AAD recommends a broad-spectrum, water-resistant sunscreen with SPF 30 or higher, such as a mineral sunscreen with zinc oxide, titanium dioxide, or both.[13]
  • Alcohol, a commonly reported trigger.[1]
  • Spicy foods, another common trigger. One hypothesis is that triggers overstimulate the TRPV1 receptor, which may be overexpressed in rosacea, contributing to flushing, warmth, and burning.[1]
  • Heat and temperature extremes, hot baths, saunas, steam rooms, exercise in high heat, and even hot beverages. Heat exposure and exercise have been associated with rosacea.[1]
  • Cold and wind, temperature extremes in both directions can provoke flares.
  • Emotional stress and anxiety, a common trigger for flares.[1]
  • Skin care products with irritating ingredients, the AAD advises avoiding products that contain alcohol, camphor, fragrance, glycolic acid, lactic acid, menthol, sodium lauryl sulfate, or urea, and never using an astringent or toner.[13]
Practical Tip: The Trigger Journal

Keep a simple daily log. Record what you ate, your activity level, weather conditions, stress levels, and how your skin looked that day. A trigger journal can help identify possible triggers that are specific to you.[1]

Rosacea vs. Acne vs. Lupus

Getting the diagnosis right matters because these three conditions look similar but require fundamentally different management. Harsh acne-style routines can irritate rosacea-prone skin; the AAD advises never using an astringent or toner for rosacea.[13] Missing lupus has serious medical consequences.

Rosacea vs. Acne Vulgaris

An important distinguishing feature: rosacea lacks comedones (blackheads or whiteheads). If you see comedones, think acne. Other differences:[5]

Rosacea versus acne: clinical distinguishing features[1][5][15]
Feature Rosacea Acne Vulgaris
Comedones (blackheads/whiteheads) Absent Present, hallmark feature
Location Central face (cheeks, nose, chin, forehead) Any area: face, chest, back, shoulders
Skin sensation Burning, stinging, heat Usually no burning or stinging
Background redness Persistent, often worsens with triggers Localized around lesions, not persistent
Flushing history Common; a distinguishing feature Not characteristic
Age of onset Mostly middle age (most cases at ages 45 to 60 in one meta-analysis) Adolescence through early adulthood (most common)
Triggers Sun, heat, alcohol, spicy food, stress Hormonal changes, oil, certain cosmetics

Rosacea vs. Lupus (Systemic Lupus Erythematosus, Malar Rash)

The malar butterfly rash of lupus erythematosus can look remarkably similar to ETR rosacea. Both cause bilateral facial redness across the cheeks and nose. The key differentiators are location, associated symptoms, and laboratory findings:

  • Nasolabial fold involvement: Rosacea involves the nasolabial folds. The lupus malar rash characteristically spares them, staying on the raised cheekbone area.
  • Systemic symptoms: Lupus causes joint pain, fatigue, fever, oral ulcers, hair loss, and kidney disease. Rosacea is confined to skin and eyes.
  • Telangiectasia and papules: Visible blood vessels and pus-filled bumps are common in rosacea. The lupus rash is typically flat or slightly raised without pustules or prominent telangiectasia.
  • Sun behavior: Both worsen with sun exposure, but the lupus rash is more photosensitive and can trigger systemic flares.
  • Duration: The lupus malar rash tends to be more persistent; rosacea flares and fades more predictably with triggers.
When to Evaluate for Lupus

If your facial redness is accompanied by joint pain, unexplained fatigue, fever, oral sores, hair thinning, or any kidney symptoms (swelling, foamy urine), see a physician promptly. An antinuclear antibody (ANA) panel and other autoimmune labs can confirm or rule out lupus. This is not a diagnosis to make from appearance alone.

Ocular Rosacea: The Often-Overlooked Subtype

I want to spend time on this because it is genuinely underdiagnosed, and missing it can cause real, lasting harm to a patient's vision.

Eye involvement is an important, underdiagnosed complication of rosacea, and the severity of eye disease often does not match the severity of skin disease.[5] The NRS states that about 20% of patients have eye findings before skin findings,[2] so people may see eye doctors for years without the connection being made; in one published case, the correct diagnosis took 10 years.[8]

What Ocular Rosacea Looks Like

The primary mechanism is meibomian gland dysfunction (MGD), the meibomian glands along the eyelid margin become inflamed and produce abnormally thick secretions that obstruct the gland openings. This disrupts the lipid layer of the tear film, leading to rapid evaporation and dry eye disease. Over time, meibomian gland atrophy can occur.

Symptoms and signs include:

  • Gritty, burning, or foreign body sensation in the eyes
  • Redness and telangiectasia along the eyelid margins
  • Crusting or flaking at the base of the eyelashes (blepharitis)
  • Recurring chalazia (eyelid lumps)
  • Chronic dry eye with intermittent watering
  • Light sensitivity (photophobia)
  • Conjunctival redness and occasional conjunctivitis
  • In severe untreated cases: corneal vascularization, scarring, or ulceration

Management of Ocular Rosacea

Treatment is graded by severity:

  • Mild: Warm compresses and eyelid cleansing with an eyelid cleanser or baby shampoo, usually twice daily, plus artificial tears for lubrication.[1][2][4] A systematic review found moderate-certainty evidence that oral omega-3 fatty acids were effective for ocular rosacea.[14]
  • Moderate: Cyclosporine eye drops used twice a day can relieve burning, stinging, and light sensitivity, and an antibiotic eye treatment may be prescribed.[4] Oral doxycycline is frequently used for ocular rosacea,[1] but a systematic review rated the evidence for doxycycline and for cyclosporine eye drops as low certainty, and the Oracea 40 mg label notes it has not been evaluated for ocular rosacea.[14][20]
  • Severe / corneal involvement: Ophthalmology referral is required, and eye disease that threatens sight is referred immediately.[4] Corneal ulcers or vascularization need specialist management immediately.

The practical takeaway: if your eyes feel chronically irritated, gritty, or dry and you have any degree of facial redness, mention both sets of symptoms to your physician. They may be the same disease.

Laser and IPL for Persistent Redness and Telangiectasia

Medications manage inflammation and reduce flares, but they have little effect on established telangiectasia (permanently dilated blood vessels visible under the skin); in one trial, neither azelaic acid gel nor metronidazole gel had a clinically appreciable effect on visible vessels.[11] For these features, lasers and intense pulsed light (IPL) are used. They can treat flushing, redness, and telangiectasia, although the quality of evidence is narrow and a systematic review rated it low to moderate certainty.[1][14]

How These Treatments Work

Pulsed-dye laser uses light that is selectively absorbed by oxyhemoglobin in superficial blood vessels, a process known as selective photothermolysis, which heats and damages the targeted vessel.[1]

Devices Used in Rosacea

  • Pulsed-dye laser (PDL, 585-595 nm): Targets the inflammatory vascular component of rosacea and has also been reported to reduce Demodex density.[1]
  • Intense pulsed light (IPL): Delivers multiple wavelengths at once rather than a single laser wavelength. It is gentler on the skin than a laser but needs more treatment sessions.[1][4]
  • KTP laser (532 nm) and long-pulsed Nd:YAG laser: KTP is especially effective for telangiectasia; Nd:YAG was designed for deeper, darker vessels and has also been used for diffuse facial redness.[1]
  • CO2 and Er:YAG lasers: Used for phymatous changes and rhinophyma, ablative lasers that remove and reshape excess tissue.[1]

These procedures require a dermatologist or trained laser specialist with experience in facial vascular treatments, because each modality needs meticulous care and training to avoid lasting damage.[1] Treatment does not cure the underlying tendency, and rhinophyma can recur after surgical procedures.[1]

Sequencing Tip

Lasers and light mainly address visible vessels and persistent redness, while medicines target inflammatory bumps. When features overlap, combination treatment across these approaches is often needed, planned with the treating dermatologist.[1]

Telehealth Dermatology for Rosacea

The main signs of rosacea, such as central facial redness, papules, and pustules, are visible, which makes remote assessment possible for many patients. In a retrospective study of asynchronous consumer-to-physician teledermatology, remote management of rosacea showed diagnostic concordance and treatment recommendations similar to in-person care.[7] A physician can review the clinical picture, screen for red flags, and discuss topical or oral treatment and trigger management; the situations listed below still need in-person care.

A 2024 retrospective study compared 220 asynchronous teledermatology cases with 80 in-person rosacea cases. It describes practice patterns and follow-up, rather than establishing universal equivalence of remote and in-person diagnosis. Its limitations include retrospective design, a predominantly White cohort, and lower follow-up adherence among remote patients.[7]

What Telehealth Can Manage Well

  • Classic papulopustular or erythematotelangiectatic rosacea with typical central facial features
  • First-time rosacea diagnosis with photo confirmation
  • Prescription and monitoring of topical agents (ivermectin, metronidazole, azelaic acid, brimonidine)
  • Initiating and monitoring low-dose doxycycline 40 mg (Oracea)
  • Follow-up visits and treatment adjustments for established rosacea
  • Trigger counseling and skincare guidance
  • Distinguishing rosacea from acne based on history and photographic assessment

When In-Person or Specialist Care Is Needed

  • Ocular rosacea with eye pain, vision changes, or corneal involvement, ophthalmology referral
  • Rhinophyma or significant phymatous changes, surgical dermatology
  • Refractory disease requiring isotretinoin, in-person dermatology for iPLEDGE enrollment and monitoring
  • Laser or IPL treatment for telangiectasia, in-person procedure
  • Systemic symptoms suggesting lupus, rheumatology evaluation

A licensed clinician can help select the appropriate setting. Uncomplicated skin symptoms may be reviewed by video or in person; eye symptoms, uncertain diagnoses, and complex or refractory disease need the relevant in-person assessment.

Putting It Together: A Practical Treatment Framework

Here is how I approach rosacea management in clinical practice, using the phenotype-based model:

Phenotype-based management framework, adapted from the NRS treatment algorithms and the evidence cited in this guide[1][2][14]
Phenotype First-Line Options For Moderate-Severe or Refractory Cases
Persistent erythema / flushing Trigger avoidance, SPF, gentle skin care; topical brimonidine or oxymetazoline for redness relief IPL or PDL laser; oral carvedilol, clonidine, or propranolol for flushing
Papules and pustules Topical ivermectin 1%, or azelaic acid 15%, or metronidazole 0.75-1%; low-dose doxycycline 40 mg (Oracea) for moderate cases Combination ivermectin + doxycycline; isotretinoin for refractory disease (dermatology referral)
Telangiectasia Trigger avoidance, SPF; IPL or PDL laser for visible vessels Repeat laser sessions; Nd:YAG for deeper vessels
Phymatous changes Treat active inflammation; carefully monitored isotretinoin may reduce early rhinophyma (dermatology referral) Surgery or ablative laser such as CO2 or Er:YAG for established rhinophyma (dermatology referral)
Ocular rosacea Warm compresses, eyelid hygiene, artificial tears, omega-3 supplements Cyclosporine eye drops, oral doxycycline; ophthalmology for corneal involvement

The AAD recommends a broad-spectrum, water-resistant sunscreen with SPF 30 or higher, gentle cleansing, and a rosacea-friendly moisturizer applied after any medication; the sun can worsen rosacea any time of the year.[13] Stripping the skin barrier with harsh products makes every phenotype worse.

Frequently Asked Questions

There is no universal best product. Azelaic acid, ivermectin, and metronidazole are established options for inflammatory bumps. Persistent redness may need a different approach. Choose with a clinician based on your features, tolerability, and prior response.[3][4][14]

The classic terms are erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea. Current management focuses on the individual features present because these patterns can overlap.[1][2]

Rosacea is usually a chronic condition with periods of flare and improvement. Treatment and gentle skin care can control symptoms; improvement does not necessarily mean the underlying tendency has disappeared.[1][5]

It may improve redness accompanying inflammatory bumps. The 15% gel label says efficacy for redness without papules and pustules has not been evaluated. Persistent flushing or visible vessels may need other treatment.[9][11][14]

Equivalence is not established in the evidence reviewed here. Prescription 15% gel and foam have formulation-specific rosacea trials and labeling; OTC cosmetic products should not be assumed interchangeable.[9][10][11][12]

Both prescription 15% formulations have evidence against their respective vehicles. Those separate trials do not establish that gel or foam is universally better. Tolerability, the specific product, access, and cost can inform the choice.[9][10][12]

AAD guidance for topical rosacea medicines describes possible slight improvement in 3 to 4 weeks and more noticeable improvement in 2 to 3 months. The gel and foam labels advise reassessment if there is no improvement after 12 weeks. Seek help sooner for significant irritation.[4][9][10]

AAD skin-care guidance puts rosacea medication before moisturizer. Cleanse gently, pat dry, and follow your prescription directions. The gel and foam labels allow cosmetics after the medication has dried.[9][10][13]

Stinging or burning can occur, especially early on, but excessive or persistent irritation should not be ignored. Stop and contact the prescriber if it is excessive or persists, or if an allergic reaction occurs.[9][10]

Do not automatically add tretinoin or exfoliating products to a sensitive rosacea routine. Ask the prescriber to review the combination and tolerability. This guide does not establish a universal combination regimen or a blanket prohibition.[9][10][13]

Rosacea can involve the eyes and eyelids, causing irritation or other symptoms. Skin azelaic acid must not be put into the eyes. Eye pain, light sensitivity, or vision changes require prompt in-person assessment.[1][4][9][10]

Selected uncomplicated cutaneous rosacea can begin with a video assessment or an in-person visit. Remote evaluation has limitations; uncertain diagnoses, eye symptoms, procedures, and complex or refractory disease need appropriate in-person or specialist care.[4][7]

References

  1. Nguyen C, Kuceki G, Birdsall M, et al. Rosacea: Practical Guidance and Challenges for Clinical Management. Clinical, cosmetic and investigational dermatology. 2024;17:175-190. https://pubmed.ncbi.nlm.nih.gov/38283794/
  2. National Rosacea Society. Rosacea Treatment Algorithms. Rosacea.org. Accessed November 7, 2026. https://www.rosacea.org/physicians/rosacea-treatment-algorithms
  3. National Rosacea Society. FDA-Approved Treatments for Rosacea. Rosacea.org. Accessed November 7, 2026. https://www.rosacea.org/patients/management-options/fda-approved-rosacea-treatments
  4. American Academy of Dermatology. Rosacea: Diagnosis and Treatment. AAD.org. Last updated April 3, 2024. Accessed November 7, 2026. https://www.aad.org/public/diseases/rosacea/treatment/diagnosis-treat
  5. Tidman MJ. Improving the management of rosacea in primary care. The Practitioner. 2014;258(1775):27-30, 3. https://pubmed.ncbi.nlm.nih.gov/25591285/
  6. Trave I, Micalizzi C, Cozzani E, et al. Papulopustular Rosacea Treated With Ivermectin 1% Cream: Remission of the Demodex Mite Infestation Over Time and Evaluation of Clinical Relapses. Dermatology practical & conceptual. 2022;12(4):e2022201. https://pubmed.ncbi.nlm.nih.gov/36534532/
  7. Shah VK, Camacho RC, English JC 3rd. Managing rosacea using asynchronous consumer to physician teledermatology as compared to in-person visits: A retrospective study. JAAD international. 2024;16:254-256. https://pubmed.ncbi.nlm.nih.gov/39135610/
  8. De Marchi SU, Cecchin E, De Marchi S. Ocular rosacea: an underdiagnosed cause of relapsing conjunctivitis-blepharitis in the elderly. BMJ case reports. 2014;2014. https://pubmed.ncbi.nlm.nih.gov/25239991/
  9. DailyMed. FINACEA (azelaic acid) gel, 15%. US prescribing information, revised January 2020. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9f40cd45-58a6-4376-9220-84bfe7d7e358
  10. DailyMed. FINACEA FOAM (azelaic acid) foam, 15%. US prescribing information, revised December 2020. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9fabd24e-4c3b-49a0-aa5f-c8d75ae67572
  11. Elewski BE, Fleischer AB Jr, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Archives of dermatology. 2003;139(11):1444-50. https://pubmed.ncbi.nlm.nih.gov/14623704/
  12. Draelos ZD, Elewski BE, Harper JC, et al. A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea. Cutis. 2015;96(1):54-61. https://pubmed.ncbi.nlm.nih.gov/26244354/
  13. American Academy of Dermatology. 7 rosacea skin care tips dermatologists recommend. Last updated April 3, 2024. Accessed November 7, 2026. https://www.aad.org/public/diseases/rosacea/triggers/tips
  14. van Zuuren EJ, Fedorowicz Z, Tan J, et al. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. The British Journal of Dermatology. 2019;181(1):65-79. https://pubmed.ncbi.nlm.nih.gov/30585305/
  15. Gether L, Overgaard LK, Egeberg A, Thyssen JP. Incidence and prevalence of rosacea: a systematic review and meta-analysis. The British Journal of Dermatology. 2018;179(2):282-289. https://pubmed.ncbi.nlm.nih.gov/29478264/
  16. Taieb A, Ortonne JP, Ruzicka T, et al. Superiority of ivermectin 1% cream over metronidazole 0.75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. The British Journal of Dermatology. 2015;172(4):1103-10. https://pubmed.ncbi.nlm.nih.gov/25228137/
  17. DailyMed. SOOLANTRA (ivermectin) cream, 1%. US prescribing information, revised October 2022. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1d5b166-ab06-4ab5-b0c6-31126238118a
  18. DailyMed. MIRVASO (brimonidine) topical gel, 0.33%. US prescribing information, revised December 2022. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6a4353f-ae69-4214-901f-e5d42a6fbde7
  19. DailyMed. RHOFADE (oxymetazoline hydrochloride) cream, 1%. US prescribing information, revised October 2023. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f7dbf12e-a802-4261-bae2-c20977698933
  20. DailyMed. ORACEA (doxycycline) capsules, 40 mg. US prescribing information, revised April 2025. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa15c93a-ff4c-447a-8a21-96da506d8997
  21. DailyMed. AMNESTEEM (isotretinoin) capsules. US prescribing information, updated August 15, 2026. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2cb63c9-f825-4991-9a2c-6260f1bbcc2c

About the Author

TeleDirectMD Medical Team

Dr. Bhavsar is a board-certified family medicine physician providing evidence-based telehealth care through TeleDirectMD across 40+ U.S. states + DC. Dr. Bhavsar manages dermatological conditions including rosacea, acne, eczema, and psoriasis through secure video visits. No insurance required.

Medically reviewed by Parth Bhavsar, MD. Updated September 27, 2026